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Papain Degrades Tight Junction Proteins of Human
Keratinocytes In Vitro and Sensitizes C57BL/6 Mice
via the Skin Independent of its Enzymatic Activity or
TLR4 Activation
Caroline Stremnitzer1,2,6, Krisztina Manzano-Szalai2,6, Anna Willensdorfer2, Philipp Starkl1, Mario Pieper3,
Peter König3, Michael Mildner4, Erwin Tschachler4, Ursula Reichart5 and Erika Jensen-Jarolim1,2
Papain is commonly used in food, pharmaceutical, textile, and cosmetic industries and is known to induce
occupational allergic asthma. We have previously shown that the papain-like cysteine protease Dermatopha-
goides pteronyssinus 1 from house dust mite exhibits percutaneous sensitization potential. We aimed
here to investigate the potential of papain itself in epicutaneous sensitization. The effects of papain on tight
junction (TJ) proteins were tested in vitro in human primary keratinocytes. Using C57BL/6 wild-type and Toll-like
receptor 4 (TLR4)-deﬁcient mice, we analyzed the sensitization potential of papain, its effects on the skin
barrier, and immune cell recruitment. Our results show that papain affects the skin barrier by increasing
transepidermal water loss, degrading TJ proteins and inducing vasodilation. When topically applied, papain
exhibited a high epicutaneous inﬂammatory potential by recruiting neutrophils, mast cells, and CD3-positive
cells and by induction of a TH2-biased antibody response. However, its high potency for speciﬁc sensitization via
the skin was TLR4 independent and, in spite of its capacity to degrade epidermal TJ proteins, does not rely on its
enzymatic function. From our data, we conclude that papain has all features to act as a strong allergen via
the skin.
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INTRODUCTION
Cysteine proteases like Dermatophagoides pteronyssinus
(Der p) 1 and papain (proteins from house dust mite and
papaya, respectively) are connected with IgE-mediated allergy
(Roelandt et al., 2008). Natural protease allergens of the peptidase
C1 family, such as Der p 1, bromelain (Zentner et al., 1997; Nettis
et al., 2001), actinidain (Mills et al., 2004; Tuppo et al., 2008),
were modeled on papain and represent its structural and
functional homologues (Mills et al., 2004). In asthma models,
the roles of cysteine proteases in TH2-immune responses have
been described (Wan et al., 1999; Asokananthan et al., 2002;
Kouzaki et al., 2009; Post et al., 2012).
Papain is concentrated in the skin of papaya fruit and is
commonly applied in pharmaceutical, food, cosmetic, and
textile industry (Ramundo and Gray, 2008; Jeong and Hur,
2010). It is an ingredient in cosmetic exfoliants or bleaching
cremes, although reports about allergic responses have
been published (Santucci et al., 1985; Niinimaki et al.,
1993; Reijula et al., 1993; van Kampen et al., 2005; Rosenthal
and Blond, 2008).
In recent studies, papain was successfully used as a surro-
gate for exogenous proteases from mite allergen extracts
(Miike and Kita, 2003; Kouzaki et al., 2009; Cunningham
et al., 2012) or to substitute for endogenous proteases, such as
mast cell tryptase (Reed and Kita, 2004; Cunningham et al.,
2012), reporting various strong immune responses to papain.
Papain has been shown to induce degranulation of human
eosinophils (Miike and Kita, 2003), trigger thymic stromal
lymphopoietin release (Kouzaki et al., 2009), and activate
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protease-activated receptor-2 (Liang et al., 2012). In
other studies, subcutaneous immunization with papain or
bromelain in combination with a second antigen (e.g.,
ovalbumin) generated reactive oxygen species, leading to
activation of dermal dendritic cells, basophils, and formation
of IgE to the secondary antigen (Secor et al., 2008; Sokol et al.,
2008, 2009; Tang et al., 2010). The study by Tang et al. has
further suggested a strong link between reactive oxygen
species, oxidized phospholipids, Toll-like receptor 4 (TLR4)-,
and TIR-domain-containing adapter-inducing interferon-b-
based signaling in the induction of TH2 responses after
subcutaneous stimulation with papain.
Although valuable for studying immunological mechanisms,
intradermal or subcutaneous sensitization models (Chambers
et al., 1998; Sokol et al., 2008; Tang et al., 2010) do not
reﬂect the natural encounter to common allergens. However,
truly epicutaneous sensitization models to relevant allergens
are not well established so far. They often rely on artiﬁcial
barrier disruption, and in most studies the food allergen
ovalbumin has been used (Wang et al., 2009; Lin et al., 2012;
Matsumoto and Saito, 2013; Savinko et al., 2013). We
recently succeeded establishing a percutaneous sensitization
protocol for Der p 1 (Szalai et al., 2012).
Considering the great structural homology with Der p 1 and its
abundance and impact on daily exposure, we investigated in
this study whether papain could be a relevant skin allergen.
Hence, we studied its effect on the epidermal barrier, and its
potential to trigger inﬂammation and an allergic response in an
adjuvant-free epicutaneous sensitization mouse model. We
analyzed recruitment of effector cells into the skin upon ﬁrst
encounter and after repeated epicutaneous papain applications
and investigated the potential contribution of TLR4 and its
cofactor lipopolysaccharide (LPS) by using TLR4-deﬁcient
C57BL/6 mice versus wild-type (WT) C57BL/6 mice.
RESULTS
TEWL is increased after treatment with papain
The epidermis, and more speciﬁcally the stratum corneum,
represents an important barrier of the body that separates
“inside” and “outside”. Impairment of the epidermis leads to
increased transepidermal water loss (TEWL), and proteases
are known to affect the integrity of epithelia (Proksch et al.,
2008, 2009).
To test the effect of papain on the skin barrier, WT C57BL/6
mice were treated epicutaneously with 15 μg papain or in the
presence of the cysteine protease inhibitor E-64 (which
irreversibly blocks enzymatic activity (Varughese et al.,
1989)) on the back skin. TEWL was substantially increased
30 and 60 minutes after treatment with active papain,
indicating an impairment of the epidermal barrier, whereas
inactivated papain slightly elevated TEWL (Figure 1a). Con-
trols treated only with buffer (distilled water) or E-64) also
exhibited only minor increases in TEWL 30 minutes after
treatment (Supplementary Figure S1A online).
Papain induces breakdown of tight junction proteins
Tight junctions (TJs) are cell–cell junctions controlling
the epithelial paracellular pathway of molecules (Proksch
et al., 2008; Brandner, 2009; Kirschner et al., 2010) and
are essential for epithelial barrier integrity. To test the
effect of papain treatment on TJs, we treated differentiated
primary human keratinocytes with different doses of
papain and analyzed cell lysates 30 minutes later by
western blot.
Papain (at concentrations as low as 1 μgml−1) caused
degradation of TJ proteins zonula occludens-1, claudin-4, and
occludin in keratinocytes in vitro (Supplementary Figure S1
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Figure 1. Immediate effects of papain on the skin barrier and tight junction
proteins. (a) WT C57BL/6 mice (n=5–8 per group) were treated topically with
15 μg active or E64-inactivated papain, and skin permeability was analyzed by
measurement of TEWL. Median+Max./Min.; *Po0.05; **Po0.01;
***Po0.001. (b) Primary keratinocytes from healthy human donors were
treated with 1 μgml−1 papain for 30 minutes, leading to breakdown
of TJ proteins ZO-1, claudin-4, and occludin. Der p, Dermatophagoides
pteronyssinus; max., maximum; min., minimum; PBS, phosphate-buffered
saline; TEWL, transepidermal water loss; TJ, tight junction; ZO-1, zonula
occludens-1, Cldn4, claudin-4; Ocln, occludin.
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online), visible as a decrease in band intensity and degrada-
tion products for zonula occludens-1. Antibodies to claudin-4
and occludin failed to detect any degradation products,
possibly because of epitope loss (data not shown).
Whereas additional papain activation with cysteine (for
reactivation of thiol groups (Yasuhara et al., 2001; Cunningham
et al., 2012)) did not signiﬁcantly enhance enzymatic activity of
papain, E-64 treatment blocked the degradation of TJ proteins
by papain (Figure 1b). Of note, controls (untreated, phosphate-
buffered saline (PBS), E-64, rDer p 2 as allergen control) did
not degrade zonula occludens-1, claudin-4, or occludin
(Figure 1b).
Epicutaneously applied papain induces a strong TH2-biased
antibody response
We next tested the epicutaneous sensitization potential of
papain in a mouse model of allergic dermatitis (Szalai et al.,
2012).
WT C57BL/6 mice were sensitized and rechallenged
(Supplementary Figure S2A–S2B online) with 15 μg papain
or with controls––namely, E-64-inactivated papain, PBS, or
allergen-control rDer p 2, which by its completely different
molecular mechanism (acting via TLR4) was chosen to com-
pare the mechanism and speciﬁcity of a papain-induced
immune response. Papain-speciﬁc IgG1 and IgE antibodies
were detectable after the third immunization, and a strong
TH2-biased antibody response had developed after the 4th
immunization (Figure 2). Inhibition of enzymatic activity by
E-64 treatment resulted in signiﬁcantly decreased speciﬁc
IgG1 and increased total IgE levels, whereas amounts of
speciﬁc IgE were not inﬂuenced.
Using epidermal lysates of WT C57BL/6 mice, develop-
ment of auto-antibodies due to breakdown of skin
proteins by papain was analyzed by a dot-blot assay. We
could not detect any immune response toward endogenous
epitopes in sera pools of immunized mice (Supplementary
Figure S3 online).
Papain challenge thickens the epidermis and induces mast cell
inﬁltration
Skin sections were evaluated for epidermal layers and dermal
thickening.
Papain-treated groups showed no increase in epidermal
layers or increased dermal thickening, whereas hyperkerati-
nization characterized by additional epidermal layers could
be observed in inactivated-papain-treated groups (Figure 3a).
Numbers of eosinophils were not increased (data not shown),
but mast cells tended to inﬁltrate the skin upon papain
treatment. Notably, signiﬁcantly more mast cells inﬁltrated the
skin of mice sensitized with inactivated papain than of mice
treated with papain active (Figure 3c).
Repeated application of papain triggers a moderate inﬂux of
CD3+ T cells, Ly-6G+, and Lang+ cells into the epidermis and to
some extent augments levels of CCL8 and numbers of Lang+
cells in the dermis
The phenotype of TH2 inﬂammation in the skin (Wang et al.,
2007; Jin et al., 2009; Wang et al., 2009) is characterized by
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Figure 2. Papain induces speciﬁc TH2-biased antibodies and high levels of total serum IgE, independent of enzymatic activity. Serum samples of all animals
were collected before sensitization (naive; not shown) and after sensitization. Levels of papain-speciﬁc IgG1, IgE, and total IgE, as well as IgG2a, IgG2b, and IgG3,
were determined by ELISA. Sera of all mice were tested separately in duplicates. Median+Max./Min.; *Po0.05; **Po0.01; ***Po0.001. Der p,
Dermatophagoides pteronyssinus; max., maximum; min., minimum.
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cutaneous hyperplasia, hyperkeratinization, and cellular inﬁltrate
consisting of CD3+ T cells and eosinophils. Other cells
being involved in the inﬂammatory response are neutrophils
and––as major antigen-presenting cells in the skin––dendritic
cells. Both, papain and inactivated papain, signiﬁcantly
increased the number of CD3+ T cells inﬁltrating the
epidermis (Figure 3b). Preliminary data, using ﬂow cytometry,
showed that active papain induces a mixed T-cell inﬁltration
comparable to another allergen (Der p 2) in context with LPS
(data not shown).
Papain but not inactivated papain showed a trend to attract
more Lang+ cells into the epidermis (Figure 4a), but Ly-6G+
cells were more likely attracted into the epidermis by
inactivated papain (Figure 4b).
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Figure 3. Alterations of skin structure and inﬁltrating cells after sensitization and re-challenge with papain. (a) Parafﬁn-embedded, H&E-stained skin samples of
papain-sensitized and -challenged mice were evaluated for a number of epidermal layers and dermal thickening. (b) Immunoﬂuorescence staining revealed
protease activity–independent inﬁltration by CD3+ T cells into the epidermis (left); × 20. (c) Parafﬁn-embedded, Giemsa-stained skin samples of papain-sensitized
and -challenged mice were evaluated for mast cell numbers. Representative data from one mouse per group are shown below; × 40. Median+Max./Min.;
*Po0.05; **Po0.01; ***Po0.001. H&E, hematoxylin and eosin; PBS, phosphate-buffered saline.
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Several studies (Wang et al., 2007; Dean et al., 2008;
Debes and Diehl, 2011; Islam et al., 2011) underlined
the CCR8-CCL8 (monocyte chemotactic protein-2) axis in
chronic inﬂammatory processes in response to allergens. Both
papain-treated groups displayed recruition of CCL8+ cells into
the epidermis and more pronounced, but still not signiﬁcant,
to the dermis (Figure 4c)
Papain treatment did not inﬂuence Ly-6G+ cell numbers
but produced increased Lang+ cell numbers in the dermis.
This response seemed to be stronger after application of E-64-
inactivated papain (Figure 4a).
Papain increases vascular permeability and immediately recruits
neutrophil granulocytes into the skin
Two-photon microscopy using Lys-eGFP (enhanced green
ﬂuorescent protein) mice enabled tracking of neutrophil
granulocytes by in-vivo imaging. High molecular weight
dextran tetramethylrhodamine (TRITC) (155 kDa) was admi-
nistered intravenously to analyze a possible increase in
vascular permeability induced by papain. Depilated ears
were treated with papain (30 μg or 15 μg), inactive papain
(inhibited by 25-molar E-64 (Cunningham et al., 2012)), or
sham control (PBS or 0.9%NaCl).
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Figure 4. Evaluation of CCL8+ cells and inﬁltration of dendritic cells and neutrophils in the skin. Skin sections were embedded in parafﬁn and stained (n=4–5
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Active papain increased vascular permeability, starting 30
minutes after application, peaking at 120 minutes (Figure 5),
and still visible after 165 minutes (data not shown), whereas
inactivated papain or sham treatment did not induce
vasodilation.
Neutrophils were strongly recruited into the skin by papain
in concentrations of 15 μg starting 30–45 minutes after
application and increasing even more over a time period of
2 hours (Figure 5). Inactivation of enzymatic activity
or sham treatment neither increased vascular permeability
nor induced recruitment of neutrophils into the skin
(Figure 5).
Enzymatic activity of papain can be detected in exfoliants
Enzymes are frequently used in cosmetics. Cystein protease
activity of papain and several cosmetic products in the
presence or absence of E-64 was measured using the substrate
Boc-Ala (Supplementary Table S1 online).
We detected enzymatic activity already in product concentra-
tions of 100 μgml−1 after 60-minute incubation with the substrate
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Figure 5. Papain recruits neutrophils into the skin and induces vascular leakage. Two-photon microscopy using Lys-eGFP mice. Dextran TRITC (155 kDa) was
administered before treatment to analyze vascular leakage of papain (15 μg in 10 μl) or control allergen on ears. 30 minutes after application of papain, vascular
leakage can be seen (excitation of dextran TRITC: 740 nm, eGFP: 940 nm). One–two hours after treatment, inﬁltration by neutrophils (GFP:490 nm) is induced by
the enzymatically active papain but not by E-64-inhibited papain. PBS controls show no vascular leakage or neutrophil inﬂux. PBS, phosphate-buffered saline;
TRITC, tetramethylrhodamine.
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(Boc-Ala). For some samples, although propagated by the manu-
facturer, enzymatic activity was not traceable in our settings.
TLR4-activation is not important in epicutaneous sensitization to
papain
Tang et al. (2010) proposed a crucial role for TLR4 activation
and a TLR4-dependent TH1 shift after subcutaneous sensitiza-
tion with papain if LPS was co-applied.
Using papain alone or in combination with LPS, we
compared the immune response between WT and TLR4− /−
mice (Supplementary Figure S2A and S2C online).
In both mouse strains, papain triggered a high
antibody response––all papain-treated mice had signiﬁcantly
elevated papain-speciﬁc IgG1 and IgE levels compared with
controls. LPS did not alter the TH2-bias of this response
(Figure 6a).
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Figure 6. No role of lipopolysaccharide (LPS) and Toll-like receptor 4 (TLR4) in epicutaneous sensitization to papain––LPS or TLR4 deﬁciency does not alter
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TLR4− /− mice developed signiﬁcantly higher speciﬁc IgG2b
and IgG3 compared with WT C57BL/6 mice, but again
independent of LPS content (Figure 6a), whereas speciﬁc
IgG2a was equally induced in all papain-treated groups.
Evaluating the systemic immune response, IL-2 levels from
stimulated splenocytes of sensitized WT mice were only
slightly elevated compared with PBS controls. Splenocytes of
TLR4− /− papain-immunized mice released signiﬁcantly higher
amounts of IL-2, whereas co-immunization with papain+ LPS
resulted in signiﬁcantly increased IL-13 production. Only minor
tumor necrosis factor-α release was detectable (Figure 6b).
DISCUSSION
The relevance of proteolytic enzymes commonly used in
industry is well documented, and their capacity to induce
respiratory allergic reactions is known (Basketter et al., 2012a,
b). Speciﬁcally, sensitization and asthma after occupational
exposure to the cysteine protease papain, such as in phar-
maceutical industry or during silk production, are prevalent
(Niinimaki et al., 1993; van Kampen et al., 2005; Rosenthal
and Blond, 2008); also, case reports about dermatitis after the
use of cosmetics containing papain (Bernstein et al., 1984;
Niinimaki et al., 1993; Reijula et al., 1993), as well as
systemic reactions after ingestion of papaya juice (Iliev and
Elsner, 1997), papaya cake (Quarre et al., 1995), or papain-
based meat tenderizer (Mansﬁeld and Bowers, 1983), have
been published. Papain is pharmaceutically used as a pro-
digestive food supplement (Miller et al., 2004; Buford et al.,
2009; Munasinghe et al., 2010; Sharma et al., 2011) and for
sanitizing necrotic wounds (Weir and Farley, 2006; Ramundo
and Gray, 2008). In spite of Food and Drug Administration
warnings to stop marketing of unapproved products contain-
ing papain in 2008, papain is still widely applied as a
cosmetic ingredient in exfoliants, dentifrices, shampoos, and
other products.
In this study, we investigated the effect of topically applied
papain on skin barrier function. In addition, we studied the
immune responses against papain in the skin.
The immediate effects of papain on skin barrier and
increased vascular leakage could be demonstrated by a
signiﬁcant increase in TEWL (Figure 1a) and by a rapid
extravasation of dextran TRITC into papain-treated skin,
respectively (Figure 5), probably via activation of protease-
activated receptor-2 (Kouzaki et al., 2009; Liang et al., 2012)
Cysteine proteases were previously shown to speciﬁcally act
on TJ proteins of lung epithelia (Wan et al., 1999; Kirschner
et al., 2010; Lambrecht and Hammad, 2012). Atopic patients
frequently show impaired skin barrier; even in non-lesional
skin, TEWL is increased compared with non-atopic patients
(Proksch et al., 2009). Enzymatic additives in, e.g., shampoos
could therefore increase the risk for barrier defects and
allergic responses. As we demonstrate, papain induces degra-
dation of tight junctional proteins in human primary
keratinocytes (Figure 1b). Our data thus indicate that the
use of enzymes in cosmetics should be handled with care as
their topical application can cause epidermal barrier impair-
ment and thereby––like house dust mite allergen Der p 1
(Wan et al., 1999)–– papain might facilitate the sensitization
to secondary allergens. Indeed, when we tested commercially
available exfoliants, enzymatic activity was demonstrable in
some (Supplementary Table S1 online) although not in all
samples––we speculate that this might be a limitation of the
method, where we tested speciﬁcally for cysteine protease
activity and no other proteolytically active enzymes (data not
shown), or due to a quenching of the signal by the cosmetic
samples.
Our data suggest that topical formulation containing papain
could permeabilize the skin barrier. Therefore, penetration
of chemicals or fragrances present in the same formulation
might be fragrances, resulting in a higher risk for induction of
allergies against these substances.
Although the allergenic potential of papain is ascribed
mainly to its proteolytic activity, E-64, an irreversible inhibitor
of cysteine proteases, did not reduce the TH2-biased immune
response of papain (Figure 2). This is in contrast to previous
reports (Chambers et al., 1998; Tang et al., 2010; Cunningham
et al., 2012). Notably, in our hands, the inactivated form of
papain retained its signiﬁcant sensitization capacity (Figure 2),
although it could no longer degrade TJ-proteins or impair the
skin barrier, nor induce acute inﬂammation. Therefore, enzy-
matic additives in cosmetics might present a risk factor even in
the absence of enzymatic activity (Supplementary Table S1
online).
We also observed recruitment of neutrophils upon applica-
tion of enzymatically active papain (Figure 5). In the in vivo
imaging model, the inactive papain did not recruit
neutrophilic granulocytes into the skin upon ﬁrst encounter,
whereas repeated application of inactive papain ﬁnally
induced an increase in neutrophils (Ly-6G+ cells) in the
skin (Figure 4b). Also, other immune cells including CD3+
cells (Figure 3b), mast cells (Figure 3c), and CCL8+ cells
were increased after repeated sensitization and rechallenge
(Figure 4).
In addition to the enzyme-mediated effects of proteases
through protease-activated receptor-2 (Asokananthan et al.,
2002), activation of TLR4 has been suggested in papain-
induced allergic responses (Tang et al., 2010). Overall, many
studies propose a major role for endotoxins in eliciting
allergic responses (Eisenbarth et al., 2002; Agrawal et al.,
2003; Kuipers et al., 2003; Hammad et al., 2009; Trompette
et al., 2009; Hongjia et al., 2010; Perros et al., 2011). To test
for the contribution of LPS as a cofactor and the activation of
TLR4 in allergic sensitization, we treated WT mice with
papain+LPS and tested our sensitization protocol in TLR4-
deﬁcient mice. In consideration of the fact that we did not
detect LPS-mediated differences in WT mice together with our
ﬁnding that TLR4− /− mice responded to papain comparably
to WT mice (Figure 6) we rule out an LPS-mediated effect as a
confounding factor. Which alternative immune receptors/
pathways are involved here will be of interest in further
studies.
In conclusion, the presented data suggest that papain
impairs the skin barrier probably by degrading TJ-proteins.
The increase in neutrophils, CD3+ cells, mast cells, and
CCL8-positive cells in skin exposed to active papain suggests
that it acts in a pro-inﬂammatory manner. Whether this
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pro-inﬂammatory effect is direct or indirect needs to be further
explored.
As the induction of a TH2-biased antibody response by
papain via the skin was independent of its enzymatic activity,
our data hence fully support the warnings of the Food and
Drug Administration to reduce and carefully evaluate the
addition of papain and related molecules to external or
internal use in humans and animals.
MATERIALS AND METHODS
Animals
Female TLR4− /− mice ((Hoshino et al., 1999; Stockinger et al., 2004;
Schellack et al., 2006)) bred under SPF conditions according to
FELASA (Federation of Laboratory Animal Science Associations)
recommendations were obtained from Biomodels Austria (University
of Veterinary Medicine Vienna, Himberg, Austria).
Female WT C57BL/6 mice were obtained from Charles River,
Germany. Experiments were conducted according to the European
Community rules for animal care, permission number BMWF-66.
009/0170-II/10b/2009 of the Austrian Ministry of Science.
Female Lys-eGFP mice (background C57BL/6) were bred under
SPF conditions according to FELASA recommendations, and experi-
ments were conducted according to the European Community rules
for animal care, permission number V242-7224.122-5 (2-1/11), of
the German Ministry of Science.
Stimulation of human primary keratinocytes
Second passage primary keratinocytes from adult skin (19–37 years;
n= 3; Cell Systems, Troisdorf, Germany) were cultured in six-well-
plates (Costar, Cambridge, MA) under conﬂuent conditions for 4 days
in a serum-free, keratinocyte growth medium, supplemented with
1.2 mM calcium (KGM-2, Lonza, Basel, Switzerland) at 37 °C and 5%
CO2. Subsequent stimulation of cells was performed with papain
(1 μgml− 1) alone or in combination with cysteine (20 μM), E-64
(1,1 μM) or Der p 2 (20 μgml− 1), and Der p 2 alone. After 1 hour,
cells were washed with PBS and lyzed in SDS-PAGE loading buffer.
Western blot analysis
Online repository
Measurement of TEWL
WT C57BL/6 mice were depilated on their backs using Veet
creme sûpreme (Veet Sûprem’Essence Easy Spray, Reckitt Benckiser
(Wallisellen, Switzerland) AG). Two days after depilation, papain
(Sigma, Vienna, Austria; 30 μg per mouse or 15 μg per mouse) or
papain+inhibitor E-64 (15 μg papain+25-fold-molar E64; Sigma), or
controls such as distilled water or E-64 alone were applied onto
depilated backs on an area of about 1.5 cm2 using Q-tips. TEWL was
measured using TewameterTM300 (Courage+Khazaka electronic
GmbH, Cologne, Germany) before application and 30 minutes and
60 minutes after application.
Experimental epicutaneous sensitization model
Each group consisted of eight animals (age: 9 weeks), and results of
two separate, independent experiments were compared.
Epicutaneous sensitization––backs of mice were carefully depi-
lated using Veet-crème-sûpreme. After a skin recovery period of
2 days, 75 μl allergen per control solutions (Supplementary Figures
S2B and S2C online) were applied onto ﬁlter discs (11 mm diameter)
placed in 12mm single chambers in Finn Chamber tape strips, on the
back for 24 hours, four times in 3-week intervals (over a total of
12 weeks); blood samples were collected before the ﬁrst and 14 days
after each sensitization (Supplementary Figure S2A online).
Three weeks after the last sensitization, mice were challenged
using the same doses as in sensitization but applied with Q-tip
instead of tape. Six hours after the challenge, mice were killed and
blood was collected by heart puncture. Samples of challenged and
unchallenged skin were taken for histological analysis.
Monitoring antibody formation by ELISA
Total or allergen-speciﬁc (papain; or rDer p 2 (not shown; Szalai
et al., 2012)) IgG or IgE antibodies were analyzed using standard
ELISA protocols (Supplementary Methods online).
Cytokine analysis
Online repository
Histological analysis
Parafﬁn-embedded sections were stained with hematoxylin and
eosin and Giemsa using standard protocols (Szalai et al., 2012);
Online repository.
Immunohistochemistry
Tissues were deparafﬁnized and treated using 30Uml− 1 Proteinase
K in PBS (Sigma) for 5 minutes at 37 °C, followed by standard
protocols (Santa Cruz Biotechnology, ImmunoCruz ABC staining
system kits; online repository). Primary antibodies were as follows: rat
anti-mouse Ly-6G antibody 1:100 (Novus Biologicals, Littleton, CO,
RB6-8C5), polyclonal rabbit anti-mouse CCL8/MCP-2 antibody
1:100 (antibody-online), and polyclonal rabbit anti-mouse Langerin
antibody 1:250 (Novus Biological), controls: rat IgG2b, rabbit IgG.
Primary antibodies were incubated over night at 4 °C (Ly-6G and
CCL8) or for 2 hours at room temperature (Langerin).
Slides were embedded with Entellans (Merck, Kenilworth, NJ) and
evaluated using HistoQuests cell analysis software from TissueGnos-
tics, Vienna, Austria. In more detail, dermal (an area of at least
800 μm2 per section per mouse) and epidermal regions (an area of at
least 200 μm2 per section per mouse) were determined manually for
analysis (to separate the dermis and the epidermis and to avoid
background due to hairfollicles) and cells were counted automati-
cally by using modules “nuclei staining” and “cell & cytoplasm”
(computer program–based automatic evalution/counting and calcu-
lation), thereby giving a percentage of positive cells to total cells.
Immunoﬂuorescence
After deparafﬁnization, antigen retrieval (Proteinase K, Roche, Basel,
Switzerland; 5 minutes, 37 °C), permeabilization (PBS/0.2%Tween20
for 5 minutes), and blocking (PBS/10% goat serum for 30 minutes at
room temperature) anti-CD3-antibody (AbD Serotec, Puchheim,
Germany; 1:50 in 5% goat serum/PBS) was incubated o/n at 4 °C.
Next, sections were incubated with Alexa-Fluor-568-conjugated goat
anti-rat antibody (LifeTechnologies, Vienna, Austria; 1:1,000 in PBS for
60 minutes at room temperature) and (4',6-diamidino-2-phenylindole;
1:2,000 in aqua dest.; for 10 minutes) and slides mounted with
ﬂuoromount-G (eBioscience, San Diego, CA). The number of T cells
was counted manually within deﬁned regions (in a blinded manner),
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and the ratio to total cell number was ﬁnally calculated by using
HistoQuest cell analysis software from TissueGnostics giving results in
% of total cell number.
The Enzymatic activity assay
Cysteine protease activity was measured as described in (Jacquet
et al., 2000; Yasuhara et al., 2001; Jacquet et al., 2002; Takai et al.,
2002; Zhang et al., 2009), with modiﬁcations using different
concentrations of papain.
Commercially available exfoliants and standard dilutions of papain
were activated for 15 minutes in 50mM TRIS, pH 7, 1 mM EDTA, and
20mML-cysteine, at 37 °C, and then tested using 12.5 μM Boc-Gln-
Ala-Arg-7-amido-4-methylcoumarinhydrochloride as substrate. Tests
were performed in duplicates and with co-incubation of 50 μM
cysteine-protease-speciﬁc inhibitor E-64.
Negative controls––activity buffer only, activity buffer+papain,
activity buffer+substrate, activity buffer+E-64. Samples were mea-
sured after 30 minutes and 60 minutes using a microplate reader
(Tecan, Groedig, Austria) at 355/460 nm. Enzymatic activity was
calculated from means of duplicates by subtraction of mean of
substrate control+(3× standard-deviation of substrate control), using
papain as a standard.
Effect of papain on inﬂux of neutrophil granulocytes and
vascular leakage by two-photon microscopy
Lys-eGFP mice (Faust et al., 2000) were anesthetized and depilated
on their ears. After retrobulbar injection of 200 μl of a 25mgml− 1
TRITC-labeled Dextran (155 kDa; Sigma), 15 μg or 30 μg papain in
10 μl PBS was applied to the ear skin. Control ears were treated with
15 μg papain and 25-fold molar concentration of the protease
inhibitor E64 (Sigma) or PBS. Z-stacks from the ear skin were
recorded over time, and the occurrence of eGFP-positive cells and
the extravasation of TRITC-dextrane were determined using a TriM
Scope two-photon microscope (LaVision BioTec GmbH, Bielefeld,
Germany) equipped with a XLUMPLFL 20×W/0.95 Objective
(Olympus, Hamburg, Germany). Excitation wavelength for visualiza-
tion of eGFP was 940 nm and 740 nm for TRITC. Emitted light was
detected by four wavelength separated PMTs (o435 nm, 453–
495 nm, 495–560 nm, and4560 nm). Image processing was carried
out using Imaris Software (Bitplane, Zurich, Switzerland).
Statistical analysis
All statistical tests were performed using one-way analysis of
variance (comparing the mean of each group with the mean of each
other group) with Tukey as the post hoc test. Data analysis and
graphs with GraphPadPrism6-software (GraphPad, San Diego, CA).
In graphs, median plus minimum and maximum is shown. Multi-
plicity adjusted P-values o0.05 were considered statistically signiﬁ-
cant. * indicates Po0.05, **Po0.01, and ***Po0.001, otherwise no
statistical signiﬁcance was reached.
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